IVF couples use legal loophole to rank embryos
Couples in the UK are using a legal grey area to screen IVF embryos for traits like intelligence and height, raising major ethical questions about 'designer babies'. Discover the implications.
Couples in the UK are using a legal grey area to screen IVF embryos for traits like intelligence and height, raising major ethical questions about 'designer babies'. Discover the implications.
Polygenic embryo screening (PES) is a new IVF add-on that claims to predict disease risk. Explore the science, the controversy, and what UK experts say about its efficacy and ethics.
A widow blames contradictory NHS guidance for her husband's death from prostate cancer. She urges men to push for PSA tests and demands clearer national screening advice.
Former Premier League goalkeeper Shaka Hislop urges men to get tested after revealing his 'aggressive' prostate cancer spread post-surgery. He highlights higher risk for Caribbean men.
New research finds telling women they have dense breasts after a mammogram increases anxiety and GP consultations. Experts call for clearer support as UK reviews screening policy.
The government's new Men's Health Strategy for England promises targeted action, but experts question if the NHS has the capacity to implement it effectively. We examine the £300m plan.
Sir Chris Hoy voices disappointment as the National Screening Committee advises against national prostate cancer screening on the NHS, citing potential harm. Learn more about the debate.
Government advisers recommend against a national prostate screening programme, stating harms outweigh benefits. Learn why and what it means for high-risk men.
The National Screening Committee advises against a national prostate cancer screening programme, citing potential for more harm than good. Learn about the new targeted proposals.
UK expert advisers are set to recommend prostate cancer screening only for men with specific genetic variants, not the wider population. Discover the new guidelines.
Nucleus Genomics offers $8,999 embryo screening for traits and diseases, raising ethical concerns about designer babies and the science behind genetic predictions.
As David Cameron backs NHS prostate screening after his treatment, we examine the disease affecting 55,300 UK men annually. Learn about symptoms, risks and the screening controversy.
With prostate cancer affecting 1 in 8 UK men, MPs and patients demand a national screening programme. Learn the risks and why early detection is crucial.
Rishi Sunak leads cross-party alliance demanding NHS prostate cancer screening for high-risk men. Over 100 MPs urge action following David Cameron's diagnosis. Join the call for equitable healthcare.
Former PM David Cameron reveals prostate cancer diagnosis and urges national screening programme. Prostate cancer kills 12,000 UK men annually. National decision expected this week.
A London GP reveals why cancer often goes undetected in routine blood tests and explains the limitations of standard health screenings. Learn what your tests really show.
Former PM David Cameron reveals his successful prostate cancer treatment and joins the campaign for a targeted NHS screening programme to save lives. Learn more about his story.
Former PM David Cameron discloses his prostate cancer treatment and urges for a targeted screening programme to help save men's lives. Join the conversation about men's health.
Exclusive private cinema experiences are coming to the UK. Discover how gourmet meals and bespoke screenings are redefining a night out at the movies.
Exclusive: New federal guidelines empower women with dense breast tissue, as survivor's story reveals diagnosis 11 months after all-clear mammogram. Learn about improved detection methods.
Krysty Sullivan's cancer was missed in a mammogram due to dense breast tissue. New Australian guidelines now mandate informing women and considering extra scans.
Major UK railway stations are implementing airport-style security screening with metal detectors and bag searches as part of a significant counter-terrorism initiative following recent threats.
Leading medical specialists are advocating for a revolutionary targeted screening programme that could dramatically reduce prostate cancer fatalities across the United Kingdom.